A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2006
12/07/2006	CA2610305A1 Formulations of lipoic acid and hyaluronic acid and/or the derivatives thereof in the pharmaceutical and cosmetic fields
12/07/2006	CA2610274A1 Benzofuran derivatives with therapeutic activities
12/07/2006	CA2610152A1 Redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers
12/07/2006	CA2610042A1 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
12/07/2006	CA2610029A1 Synergic combinations comprising a quinoline compound and other hiv infection therapeutic agents
12/07/2006	CA2610014A1 Fluoroalkylamine derivatives as cathepsin inhibitors
12/07/2006	CA2609930A1 Fused imidazole derivatives and use thereof as aldosterone synthase inhibitors
12/07/2006	CA2609818A1 Use of a steroid sulphatase inhibitor for inhibiting the synthesis of androstenedione and/or testosterone
12/07/2006	CA2609784A1 Novel method of treating hyperlipidemia
12/07/2006	CA2609783A1 Combination of a cannabinoid-1- receptor-antagonist and a microsomal triglyceride transfer protein inhibitor for treating obesity or mainataining weight loss
12/07/2006	CA2609649A1 Tigecycline and methods of preparing 9-aminominocycline
12/07/2006	CA2609522A1 Indacterol derivatives and phosphodiesterase inhibitors for the treatment of airway diseases
12/07/2006	CA2609513A1 Novel heterocyclic compounds as positive allosteric modulators of metabotropic glutamate receptors
12/07/2006	CA2609429A1 Medicament containing a betamimetic in conjunction with an anticholinergic and a pde iv inhibitor
12/07/2006	CA2609428A1 Bicyclic 6-alkylidene-penems as class-d beta-lactamases inhibitors
12/07/2006	CA2609388A1 Novel piperidine derivative
12/07/2006	CA2609355A1 Organic compounds
12/07/2006	CA2609307A1 Methods of purifying tigecycline
12/07/2006	CA2609306A1 Tigecycline and methods of preparation
12/07/2006	CA2609264A1 Tigecycline and methods of preparing 9-nitrominocycline
12/07/2006	CA2609196A1 Compositions and methods for treating pain
12/07/2006	CA2609193A1 Methods and compositions for managing psychotic disorders
12/07/2006	CA2609032A1 Method for producing a nucleic-acid-containing complex preparation
12/07/2006	CA2608916A1 Heterocyclic spiro-compounds as aldosterone synthase inhibitors
12/07/2006	CA2608879A1 Combination of hmg-coa reductase inhibitors amd mtor inhibitors
12/07/2006	CA2608865A1 Substances having body mass redistribution properties
12/07/2006	CA2608819A1 Piperidin-4-yl-amide derivatives and their use as sst receptor subtype 5 antagonists
12/07/2006	CA2608709A1 Treatment of liver diseases in which iron plays a role in pathogenesis
12/07/2006	CA2608704A1 Combinations of indacaterol derivatives and other agents for the treatment of airway diseases
12/07/2006	CA2608702A1 Ergoline derivatives and their use as chemokine receptor ligands
12/07/2006	CA2608504A1 Inhibition of neuronal damage
12/07/2006	CA2608212A1 Novel piperidine carboxylic acid amide derivatives
12/07/2006	CA2607862A1 C5a receptor antagonists
12/07/2006	CA2606110A1 Solid forms of 1-(5-(1h-1,2,4-triazol-5-yl)(1h-indazol-3-yl))-3-(2-piperidylethoxy)benzene
12/07/2006	CA2575045A1 Furanopyridine derivatives and methods of use
12/06/2006	EP1728865A1 Treatment of cervical cancer
12/06/2006	EP1728863A2 C-class oligonucleotide analogs with enhanced immunostimulatory potency
12/06/2006	EP1728862A1 Methods and compositions for RNA interference
12/06/2006	EP1728802A2 ErbB3 antibodies
12/06/2006	EP1728797A2 Regulators of the hedgehog pathway, compositions and uses related thereto
12/06/2006	EP1728794A1 Maleate addition salt of hydropyridine derivatives
12/06/2006	EP1728793A1 9-substituted 8-oxoadenine compound
12/06/2006	EP1728792A1 8-oxoadenine compound
12/06/2006	EP1728791A1 Composition for solid pharmaceutical preparation of solifenacin or salt thereof
12/06/2006	EP1728790A1 Shp-2 inhibitors, pharmaceutical compositions comprising them and their use for treating phosphatase-mediated diseases
12/06/2006	EP1728789A1 Antibiotic fki-1778 and process for producing the same
12/06/2006	EP1728784A1 Fluorene derivative
12/06/2006	EP1728514A1 Uses of oligonucleotides stimulatory of the mesenchymal stem cell proliferation
12/06/2006	EP1728513A2 Stable desloratadine compositions
12/06/2006	EP1728512A1 Controlled-leaching preparation and process for producing the same
12/06/2006	EP1728511A1 New use of phenethicillin and salts thereof.
12/06/2006	EP1728510A2 Treating cancer by increasing intracellular malonyl coA levels
12/06/2006	EP1728509A1 Periodontal ligament-protecting agent
12/06/2006	EP1728508A1 Medicine for prevention or treatment of frequent urination or urinary incontinence
12/06/2006	EP1728507A1 Compositions for treating or preventing cardiovascular disease
12/06/2006	EP1728506A1 Coenzyme q composition with long-term persistence in blood
12/06/2006	EP1728505A1 Preparation with elevated content
12/06/2006	EP1728504A1 Emulsion stabilizer
12/06/2006	EP1727901A2 Materials and methods for treatment of cancer
12/06/2006	EP1727883A2 Vegetable based dioxanone derivatives, synthesis and uses thereof
12/06/2006	EP1727822A1 Novel compounds for modulating cell proliferation
12/06/2006	EP1727821A1 Substituted diazabicycloheptanes and their use as protein kinase inhibitors
12/06/2006	EP1727820A2 Amine derivatives
12/06/2006	EP1727819A1 Novel dichloro-phenyl-pyrido¬2,3-d\|pyrimidine derivatives, their manufacture and use as pharmaceutical agents
12/06/2006	EP1727817A1 Azabicyclooctan-3-one derivatives and use thereof
12/06/2006	EP1727815A1 Ether derivatives, their manufacture and use as pharmaceutical agents
12/06/2006	EP1727814A1 Nucleoside analogues with antiviral activity
12/06/2006	EP1727813A1 2-propanol and 2-propylamine derivatives and their use as glucocorticoid ligands
12/06/2006	EP1727812A1 Novel cycloalkyl-containing 5-acylindolinones, their preparation and their use as pharmaceutical products
12/06/2006	EP1727811A1 New compounds for the inhibition of angiogenesis and use of thereof
12/06/2006	EP1727809A1 Substituted morpholine and thiomorpholine derivatives
12/06/2006	EP1727808A2 Biaryl amino acids and their use in dna binding oligomers
12/06/2006	EP1727806A1 2,4-diaminopyrimidines and their use for inducing cardiomyogenesis
12/06/2006	EP1727803A1 Processes for preparing substituted n-aryl-n'-[3-(1h-pyrazol-5-yl)phenyl] ureas and intermediates thereof
12/06/2006	EP1727802A1 Substituted quinoline compounds for use as selective estrogen receptor modulator
12/06/2006	EP1727801A1 Piperazines useful for treating pain
12/06/2006	EP1727800A1 Semicarbazide derivatives as kinase inhibitors
12/06/2006	EP1727799A1 Novel alkyl-containing 5-acylindolinones, their preparation and their use as pharmaceutical products
12/06/2006	EP1727798A1 Novel aryl-containing 5-acylindolinones, the production thereof and their use as medicaments
12/06/2006	EP1727795A1 Process for the production of atorvastatin calcium in amorphous form
12/06/2006	EP1727794A1 Novel benzyl(idene)-lactam derivatives
12/06/2006	EP1727793A1 Substituted azetidine compounds as cyclooxygenase-1 - cyclooxygenase-2 inhibitors, and their preparation and use as medicaments
12/06/2006	EP1727791A1 Polymorphic forms of (1-{3-[3-(4-cyano-3-methoxy-phenyl)ureido]-phenyl}-ethyl)-carbamic acid-2-cyano-1-ethyl-ethyl ester
12/06/2006	EP1727790A1 Phenylaminoethanol derivatives as beta2 receptor agonists
12/06/2006	EP1727789A2 Phenylethanolamine derivatives as beta-2 agonists
12/06/2006	EP1727788A1 Opioid receptor antagonists
12/06/2006	EP1727786A1 Acid addition salts of 5-aminolevulinic acid or its derivatives
12/06/2006	EP1727785A1 Phenyl indan derivatives
12/06/2006	EP1727784A1 Improved process for preparation of gabapentin
12/06/2006	EP1727567A2 Aptamer therapeutics useful in the treatment of complement-related disorders
12/06/2006	EP1727566A2 Conjugated psychotropic drugs and uses thereof
12/06/2006	EP1727564A1 Cd44-targeting for reducing/preventing ischemia-reperfusion-injury
12/06/2006	EP1727559A1 Use of fgf-21 and a thiazolidinedione for treating type 2 diabetes
12/06/2006	EP1727554A2 Methods of treating psychiatric, substance abuse, and other disorders using combinations containing omega-3 fatty acids
12/06/2006	EP1727551A1 Pharmaceutical composition comprising a benzodiazepine derivative and a inhibitor of the rsv fusion protein
12/06/2006	EP1727550A1 Pharmaceutical composition comprising a benzodiazepine derivative and an inhibitor of the rsv fusion protein
12/06/2006	EP1727549A1 Intranasal benzodiazepine compositions
12/06/2006	EP1727548A2 Use of carboxypeptidase g for combating antifolate toxicity
12/06/2006	EP1727547A1 Compounds for the sustained reduction of body weight
12/06/2006	EP1727546A2 Methods and formulations for protecting cells, and for treating diseases and conditions by optimizing the intracellular concentration of nad

1 ... 3978 3979 3980 3981 3982 3983 3984 3985 3986 3987 3988 3989 3990 3991 3992 3993 3994 3995 3996 3997 3998 ... 7860